Periodically examine patients in long-term treatment (several mth or longer) for possible changes in the nasal mucosa. Discontinue therapy if localized fungal infection of the nose or pharynx develops or nasopharyngeal irritation is persistent. Patients w/ active or quiescent tuberculous infections of the resp tract, untreated fungal, bacterial, systemic viral infections or ocular herpes simplex; transferred from long-term administration of systemically active corticosteroids. Joint & or muscular pain, lassitude, depression may be experienced by patients transferring from systemic corticosteroids. Risk of exposure to certain infections (eg, chickenpox, measles) in the immunosuppressed. Nasal septum perforation or increased IOP; growth retardation in childn. Regularly monitor height of childn receiving prolonged therapy. Adrenal suppression w/ higher than recommended doses. Consult physician if signs or symptoms of severe bacterial infection are observed. Unilateral polyps, polyps associated w/ cystic fibrosis, polyps that completely obstruct the nasal cavities. Pregnancy & lactation. Rhinosinusitis in childn <12 yr. Nasal polyposis in childn & adolescents <18 yr.